Inflammation News and Research

RSS

Top institutions in the U.S. win Cancer Research UK's Grand Challenge competition

The U.S. will lead three new global research projects, tackling some of the biggest challenges in cancer research, it was announced today by Cancer Research UK.

23 Jan 2019

Synthetic compound from flaxseed can improve heart function in mice with sepsis

Sepsis is a life-threatening systemic inflammatory condition that develops in response to infection. One of its major complications is cardiovascular dysfunction, in which deterioration of the heart muscle, driven by decreased energy production resulting from reduced oxygen and nutrient supplies, frequently ends in organ failure.

23 Jan 2019

New findings challenge existing strategies for fighting infectious diseases and germs

Do the same laws of biodiversity which apply in nature also apply to our own bodies and homes? If so, current hygiene measures to combat aggressive germs could be, to some extent, counterproductive.

22 Jan 2019

Rutgers researchers discover cause of bone loss in people with joint replacements

Rutgers researchers have discovered the long-sought reason that many people with joint replacements experience harmful inflammation and bone loss.

22 Jan 2019

Scientists find bacterial extracellular vesicles in human blood

Belgian scientists have come to the surprising finding that vesicles coming from gut bacteria, are present in blood of patients with HIV, inflammatory bowel disease and cancer.

22 Jan 2019

FSU study provides better understanding of spinal cord injuries

Thousands of people worldwide suffer severe spinal cord injuries each year, but little is known about why these injuries often continue to deteriorate long after the initial damage occurs.

21 Jan 2019

Study to investigate new targeted oral treatments for severe asthma

A £2.68 million study to investigate the effective use of antibiotics to treat certain types of severe asthma is being spearheaded by researchers in Leicester.

21 Jan 2019

Researchers uncover specific microbial signatures of intestinal disease

Researchers from the Department of Biomedical Research of the University of Bern and the University Clinic of Visceral Surgery and Medicine of the Inselspital Bern, Switzerland, have discovered that changes in the composition of the intestinal bacteria in patients with chronic inflammatory bowel disease affect the severity of the disease and the success of therapy.

21 Jan 2019

New study extends our knowledge of the link between miRNAs and cancer

The abnormal expression of different classes of molecules is known to be linked to various types of cells becoming cancerous.

21 Jan 2019

UNIST researcher named as recipient of Merck’s 2018 Life Science Awards

Jun Ho Lee, a doctroral student in Life Sciences at UNIST, has been named as a recipient of Merck's 2018 Life Science Awards in Tumor Biology, receiving the grand prize of $10,000.

21 Jan 2019

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer.

18 Jan 2019

Researchers identify new therapeutic target in the fight against chronic liver diseases

Chronic liver disease is known as the silent killer, as it shows no obvious symptoms until the disease has progressed to an advanced stage. Therefore, making a proper diagnosis in the early stage of disease progression can be a clinical challenge.

18 Jan 2019

New nuclear medicine method could improve detection of primary and metastatic melanoma

A new nuclear medicine method for detecting malignant melanoma, one of the most aggressive skin cancers, has been successfully tested for the first time in humans and could improve detection of both primary and metastatic melanoma.

18 Jan 2019

Research brings new hope to treating degenerative brain diseases

Alzheimer's disease is the most representative degenerative brain disease, accounting for 60 to 80% of all dementia cases. In search for new mechanism for AD, the research team led by Professor Seong-Woon Yu of Brain and Cognitive Sciences paid attention to the autophagy of microglia, brain immune cells, is suppressed by inflammation.

17 Jan 2019

New anti-inflammatory compound acts as 'surge protector' to reduce cancer growth

A new anti-inflammatory compound developed at the University of California, Davis, acts as a "surge protector" to suppress inflammation and reduce cancer growth, at least in mouse models of cancer.

17 Jan 2019

Study reveals potential pathway for endothelial cells to avoid apoptosis

Cell death is an important aspect of tissue homeostasis, as well as inflammation and disease pathogenesis related to infection, injury, and tumor growth.

17 Jan 2019

Study: Ham bones contain peptides that could have cardioprotective effects

Drinking bone broth is a recent diet fad that proponents claim fights inflammation, eases joint pain and promotes gut health.

16 Jan 2019

OSSIO granted FDA 510(k) market clearance for OSSIOfiber Bone Pin Family

OSSIO, an orthopedic fixation company, today announced that its OSSIOfiber Bone Pin Family has received 510(k) market clearance from the U.S. Food and Drug Administration.

16 Jan 2019

Salk team uses new model to study health effects of AMP-activated protein kinase

The metabolic protein AMPK has been described as a kind of magic bullet for health. Studies in animal models have shown that compounds that activate the protein have health-promoting effects to reverse diabetes, improve cardiovascular health, treat mitochondrial disease--even extend life span.

16 Jan 2019

Research reveals novel approach to suppressing chemotherapy-induced tumor growth

Following up on a groundbreaking 2018 study in which BIDMC's Dipak Panigrahy, MD, demonstrated that dead and dying cancer cells killed by conventional cancer treatments paradoxically trigger inflammation that promotes tumor growth and metastasis, a new study led by Allison Gartung, PhD, describes a novel approach to suppressing chemotherapy-induced tumor growth in an ovarian cancer model.

16 Jan 2019

Inflammation News and Research

Top institutions in the U.S. win Cancer Research UK's Grand Challenge competition

Synthetic compound from flaxseed can improve heart function in mice with sepsis

New findings challenge existing strategies for fighting infectious diseases and germs

Rutgers researchers discover cause of bone loss in people with joint replacements

Scientists find bacterial extracellular vesicles in human blood

FSU study provides better understanding of spinal cord injuries

Study to investigate new targeted oral treatments for severe asthma

Researchers uncover specific microbial signatures of intestinal disease

New study extends our knowledge of the link between miRNAs and cancer

UNIST researcher named as recipient of Merck’s 2018 Life Science Awards

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

Researchers identify new therapeutic target in the fight against chronic liver diseases

New nuclear medicine method could improve detection of primary and metastatic melanoma

Research brings new hope to treating degenerative brain diseases

New anti-inflammatory compound acts as 'surge protector' to reduce cancer growth

Study reveals potential pathway for endothelial cells to avoid apoptosis

Study: Ham bones contain peptides that could have cardioprotective effects

OSSIO granted FDA 510(k) market clearance for OSSIOfiber Bone Pin Family

Salk team uses new model to study health effects of AMP-activated protein kinase

Research reveals novel approach to suppressing chemotherapy-induced tumor growth

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News